|
- 2019
Low-dose of olanzapine has ameliorating effects on cancer-related anorexiaDOI: 10.2147/CMAR.S191330 Keywords: chemotherapy, nausea, cachexia, appetite, end-of-life care, tranquilizer Abstract: Olanzapine (OLZ) has become well-known for its antiemetic effects on chemotherapy-induced nausea and vomiting. However, it remains unclear whether OLZ also has efficacy for treating cancer-related anorexia. This study, therefore, retrospectively examined whether or not OLZ administration affects the food intake in anorexic cancer patients who exhibit neither nausea nor vomiting
|